Categories
Latest Industry Intelligence
This latest ebook sponsored by Sino Biological features insight on how the global drug discovery and [...]
Cell therapy research has never been more exciting with all of the research ongoing. Download [...]
…tumours. This breakthrough marks the first of its kind in China and represents a significant milestone in innovative drug discovery pathways for cancer treatment. According to data and analytics company…
Salipro Biotech, in collaboration with AstraZeneca, has published data from a study which describes a novel method to directly extract membrane proteins from cells into lipid Salipro nanoparticles, enabling structure-function…
Destiny Pharma, a UK-based clinical stage biotechnology company focused on the development of novel medicines to prevent life threatening infections, has published landmark XF-73 clinical data in the US peer…
…global net sales. Macomics’ ENIGMAC macrophage drug discovery platform integrates large volume human data sets, custom cell models, and human macrophage genome editing capability to discover novel targets and unlock…
New data suggest that AKL Therapeutics’ investigational oral osteoarthritis (OA) drug APPA may have a dual effect on age-related cellular senescence. Senescence, a process in which cells stop dividing, plays…
…Perelman School of Medicine at the University of Pennsylvania. ‘Encouraging’ data for monoclonal antibody in advanced cancers Purple Biotech has revealed positive new results from exploratory analyses conducted as part…
…to implement a biomarker-driven strategy that could identify patients who will benefit from CM24,” said Gil Efron, Chief Executive Officer, Purple Biotech. “We look forward to further data that may…
…drug discovery solutions Optibrium and PostEra plan to integrate Optibrium’s StarDrop platform with PostEra’s Manifold software. StarDrop’s drug discovery software includes de novo compound design, optimisation, and data analysis, and…
…in the key secondary endpoint of overall survival (OS) was also observed, but these data were not yet mature. Patients in the trial will be followed for a subsequent final…
…further evaluate it as both a potential monotherapy and in combination with standard treatments once a Phase II dose is confirmed. Preliminary data from this study was presented at the…